The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. - Test2 - elhamkhani - TriplyDB

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

http://www.wikidata.org/entity/Q37946259

about

Mechanisms of dopamine transporter regulation in normal and disease states Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects MicroRNAs Modulate Interactions between Stress and Risk for Cocaine Addiction Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders The Transcription Repressor REST in Adult Neurons: Physiology, Pathology, and Diseases(1,2,3)κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction Molecular mechanisms of synaptic remodeling in alcoholism Drug models of schizophrenia The subjective experience of acute, experimentally-induced Salvia divinorum inebriation Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence A (-)-kolavenyl diphosphate synthase catalyzes the first step of salvinorin A biosynthesis in Salvia divinorum.Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.Reviewing the ketamine model for schizophrenia.Identification of novel functionally selective κ-opioid receptor scaffolds.An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats.Opioid receptor desensitization: mechanisms and its link to tolerance In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor A functional polymorphism in the prodynorphin gene affects cognitive flexibility and brain activation during reversal learning.Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system.The role of the dynorphin/κ opioid receptor system in anxiety.Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner.Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans.Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors.Opioid receptors: distinct roles in mood disorders.Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs.Stress, κ manipulations, and aversive effects of ethanol in adolescent and adult male rats.Species differences in the effects of the κ-opioid receptor antagonist zyklophin.Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets.Opiate dependence in schizophrenia: case presentation and literature review.The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review.The epigenetic regulation of the opioid system: new individualized prompt prevention and treatment strategies.Structure-Activity Relationships of [des-Arg7]Dynorphin A Analogues at the κ Opioid Receptor.Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

P2860

Q24598750-DD1098B1-9080-455C-BE41-7A25A7D6BF11 Q24616738-1C187DDB-4E7B-43EC-AF84-3243EDD2AA23 Q26746045-95D40A94-1192-4846-9112-2DD5F77C141D Q26781580-1C0C685D-FCFD-43F0-A810-2BB6D59E8D82 Q26783252-C7717B23-D7C4-4A7D-BF0E-C6AF2C5D5DF3 Q26864309-053702B0-079E-40B3-8F8A-AD289BA82CB4 Q28080843-A23F17D2-1C78-4BD9-B8E3-4553ACB4F4D6 Q28084198-995E44F1-06BE-4FB3-B2F9-5A615D3EBA07 Q28257248-DA8940FB-F302-4F84-A7C2-3C35E3CBAFF0 Q28267475-878CAD2B-0F6A-43CE-980C-F512AA06DD43 Q30435816-A5372A14-ADA4-4FF9-8CD4-7B814B41BBAF Q30453617-C268C56A-7999-4A9C-9C5C-4D6F65C693FA Q33719556-2BD4E05D-F704-4C60-A4C6-91D16138DF83 Q33725088-B8B12F80-885E-4544-B880-A5667F2B2399 Q34046060-595A9C28-CFD6-4B9D-8E51-0D33AB1579D0 Q34376764-D5E3C4B9-09C0-4538-9158-EEBC503603E5 Q34421107-2E197A3D-1240-4568-A946-176ACDB1D527 Q34499320-F906A8F7-2DFF-4274-8598-20CC6EF04ACC Q34656885-D09D73D2-378B-4FE4-92BE-34C3E58FB5E7 Q34729984-2BE62BE2-680F-44F3-A313-7F9AFAEF6B1C Q35182618-7E3A09A8-5FFD-4C4D-9BF7-0021FC30F3CA Q35812973-0FB44464-E063-4CD3-A08A-7FFB5B443E1B Q36281799-3EB8AA8D-57D9-4913-ADD2-1F2ADF7471BE Q36287728-C73D1E28-9DE9-4718-9626-6D2772618D32 Q36350809-66459494-F798-4D3C-BB83-4218E24A8F96 Q36363810-628A803E-AFEA-4D7E-BA5D-68FB8F81D9C1 Q36389121-706AACB1-0FED-4813-9274-31C60B13548D Q36675341-69AA9BBC-B0E5-4170-AE35-39B88444226B Q36894439-8A6891B0-D4C5-465E-B60D-587C44847FBF Q36897592-0516A139-2A8F-4DAE-937F-4062A4F7C43C Q36934953-7C5713DD-601E-49F9-9D41-95DE1A50614D Q37030182-FDD8D8F0-1369-43EA-A889-31F7AC121C80 Q37177752-AADBE6C5-AE6A-4E80-851D-C382D75E9C05 Q37621277-CA1EAE7A-0830-4E87-A2E6-2DA18BD75B04 Q38111109-1DF42B44-F812-471E-93DF-2EC33A94FE3A Q38267760-54195866-1C27-475A-9F9D-0CA3B5ED853B Q38270731-93EFEF16-A34A-4C30-B7C7-E13F2E80345B Q38479752-7C63BDC1-696E-4D16-BFFE-A1AB4802B3EC Q38734980-6347E018-134C-4AFA-BD55-9B9B9400F262 Q39251520-B4CAB212-DEAF-40E8-8987-CEA585646AC7

P2860

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

http://www.wikidata.org/entity/Q37946259

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

@en

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

@nl

type

label

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

@en

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

@nl

prefLabel

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

@en

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

@nl

P1433

Q37946259-EEA4F8C0-E40B-4704-B814-C325151DF7C0

P1476

Q37946259-FF9C4405-7912-47B9-8CD6-91B3A6961312

P2093

Q37946259-E4DC64AE-DB91-4F6E-B6A7-F8B95A8BEE02

Q37946259-E8122E02-F307-45B7-8962-F5E0B2E67ACC

Q37946259-F6F6749B-3A77-4010-94DB-39C291F28F8B

P2860

Q37946259-000ECE73-B0F3-4CB9-BEFA-E4E73201C84B

Q37946259-028436D5-CFE5-44F5-93DD-BD5CC988E87F

Q37946259-035D8A3D-6771-478C-A8AE-650D95995078

Q37946259-03806869-7361-46F6-8DFF-B12B85122A4A

Q37946259-038706F6-55DF-4A0D-99AC-C9614254E50B

Q37946259-039BA2E6-DC4C-40DE-9805-9CDC037827A4

Q37946259-03AD52F8-14A6-459D-9150-03091BBB6E17

Q37946259-04E1A131-4881-495D-B3FE-B867EE86E1E8

Q37946259-06CE900B-5DF0-48B1-AA59-EAD80E5A314D

Q37946259-06D0441B-1025-4DDA-83E2-AF7DAA5F5B91

P2888

Q37946259-AECEF549-EF05-4CEB-BC75-3EBA5AA7B1DA

P304

Q37946259-6F8CB996-AB26-44C6-A254-E7B8D0A508B5

P31

Q37946259-51970CAA-E819-409C-BF6D-43683E401746

P356

Q37946259-2170CE79-FE56-4B4D-9019-BDDECFA964DE

P433

Q37946259-22230270-7D95-446D-8192-E5402DFA8038

P478

Q37946259-0E4F345F-DC2C-4DC9-B75E-75AF36BCD2A4

P577

Q37946259-17912A20-FCCD-46F3-9181-619ED13E2DD6

P5875

Q37946259-BA090AF9-EF84-41B9-87AB-69B389968428

P698

Q37946259-F7141C53-5403-49D8-864A-E30621E9A6FF

P921

Q37946259-339B9A47-6FCB-4977-90CF-44D1308E25B9

Q37946259-72cc6630-ad10-436c-84fe-9c9fdfb7d3cc

P356

S00018-011-0844-X

P1433

Cellular and Molecular Life Sciences

P1476

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

@en

P2093

H A Tejeda

http://www.w3.org/2001/XMLSchema#string

R Henriksson

http://www.w3.org/2001/XMLSchema#string

T S Shippenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Ancient and recent positive selection transformed opioid cis-regulation in humans

Complete sequencing and characterization of 21,243 full-length human cDNAs

Reasons for increased substance use in psychosis

Dopaminergic Terminals in the Nucleus Accumbens But Not the Dorsal Striatum Corelease Glutamate

DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription

Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element.

Ca2+-dependent block of CREB-CBP transcription by repressor DREAM.

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

P2888

s00018-011-0844-x

P304

857-896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-011-0844-X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51719655

http://www.w3.org/2001/XMLSchema#string

P698

22002579

http://www.w3.org/2001/XMLSchema#string

P921